Barnaby Nelson

发表

Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

Catalina V. Mourgues-Codern, Albert R. Powers, S. A. Wijtenburg, 2023, medRxiv.

Influence of cannabis use on incidence of psychosis in people at clinical high risk

P. Delespaul, C. Pantelis, D. Ståhl, 2023, Psychiatry and clinical neurosciences.

Network-Based Spreading of Gray Matter Changes Across Different Stages of Psychosis.

Ben D. Fulcher, A. Fornito, H. Yuen, 2023, JAMA psychiatry.

Treatment of schizotypal disorder: a protocol for a systematic review of the evidence and recommendations for clinical practice

B. Ebdrup, L. Glenthøj, A. Polari, 2023, BMJ open.

The temporal association between social isolation, distress, and psychotic experiences in individuals at clinical high-risk for psychosis.

M. Kempton, L. Valmaggia, R. van Winkel, 2024, Psychological medicine.

Psychosis superspectrum I: Nosology, etiology, and lifespan development.

A. Docherty, Katherine G. Jonas, Tyrone D Cannon, 2024, Molecular psychiatry.

Transdiagnostic risk identification: A validation study of the Clinical High At Risk Mental State (CHARMS) criteria

H. Yuen, J. Hartmann, P. Amminger, 2024, Psychiatry Research.

Cannabidiol for At Risk for psychosis Youth (CanARY): A Randomised Controlled Trial

H. Yuen, C. Mihalopoulos, M. Berger, 2021 .

Normative Modeling of Brain Morphometry in Clinical High Risk for Psychosis

Kristen M. Haut, D. Mathalon, T. V. van Erp, 2023, JAMA psychiatry.

Harmonizing early intervention strategies: scoping review of clinical high risk for psychosis and borderline personality disorder

V. Lingiardi, A. Tanzilli, A. Polari, 2024, Frontiers in psychology.